David Danese

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

David Danese is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, drug utilization review, and comparative disease severity.

Publications per year

2021–2023

Publications

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Laura Obici, Senda Ajroud‐Driss, Kon‐Ping Lin et al. · Neurology and Therapy · 2023 · 20 citations · Full text

Medicine, Neurology, Pharmacotherapy +11

Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study

Xiangling Wang, David Danese, Thomas Brown et al. · Frontiers in Medicine · 2021 · 12 citations · Full text

Medicine, Internal Medicine, Nephrology +15

1–2 of 2